Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 116.89 0.38 0.33% 11.77%
Acadia Pharmaceuticals 18.84 0.05 0.27% -66.75%
Acorda Therapeutics 2.69 -0.17 -5.94% 302.82%
Agios Pharmaceuticals 35.51 -0.94 -2.58% -23.34%
Alnylam Pharmaceuticals 180.74 -7.79 -4.13% 39.13%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 203.47 2.38 1.18% -8.36%
Biogen 236.11 -6.79 -2.80% -1.69%
Bluebird Bio 10.33 -0.17 -1.62% -76.57%
BioMarin Pharmaceutical 87.40 -0.18 -0.21% 11.05%
Bristol-Myers Squibb 54.64 -1.89 -3.34% -12.44%
Esperion Therapeutics 8.68 0.90 11.57% -69.35%
Gilead Sciences 70.65 0.38 0.54% 16.45%
GW Pharmaceuticals 218.96 0 0% 108.53%
Intercept Pharmaceuticals 16.43 -0.67 -3.92% -53.73%
Insmed 27.12 -1.81 -6.26% -30.48%
Ionis Pharmaceuticals 29.05 -0.71 -2.39% -43.18%
J&J 159.75 0.55 0.35% 10.42%
Eli Lilly 254.83 -5.54 -2.13% 74.96%
Merck & Co 74.89 -4.27 -5.39% -6.84%
Moderna Inc 368.51 38.88 11.80% 141.27%
Neurocrine Biosciences 84.74 -2.24 -2.58% -10.74%
Novartis 74.24 -0.48 -0.64% -9.76%
Omeros 7.07 -0.36 -4.85% -39.00%
Puma Biotechnology 3.08 -0.15 -4.50% -72.62%
Pfizer 52.40 -1.60 -2.96% 36.78%
PTC Therapeutics 36.89 -1.17 -3.07% -41.04%
Ultragenyx Pharmaceutical 73.71 -2.78 -3.63% -37.82%
Regeneron Pharmaceuticals 654.40 11.05 1.72% 26.81%
Roche Holding 357.50 -1.10 -0.31% 19.55%
Sanofi 85.61 0.60 0.71% 1.06%
Seattle Genetics 165.31 -4.19 -2.47% -2.94%
Sarepta Therapeutics 79.86 0.24 0.30% -43.31%
United Therapeutics 194.00 0.36 0.19% 46.26%
Vertex Pharmaceuticals 190.11 6.52 3.55% -16.53%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%

Indexes Price Day Year
NASDAQ 15783 291.18 1.88% 29.38%
US500 4663 60.65 1.32% 28.74%

Alexion Pharmaceuticals
Alexion Pharmaceuticals, Inc. (Alexion), is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its marketed product Soliris (eculizumab) is the first and only therapeutic approved for patients with two ultra-rare and severe disorders resulting from chronic uncontrolled activation of the complement component of the immune system: paroxysmal nocturnal hemoglobinuria (PNH), an ultra-rare and life-threatening blood disorder, and atypical hemolytic uremic syndrome (aHUS), an ultra-rare and life-threatening genetic disease. The Company is also evaluating other indications for Soliris in other diseases in which chronic uncontrolled complement activation is the underlying mechanism, and it is progressing with other biotechnology product candidates in ultra-rare and severe disorders, which are in various stages of development.